| Novo Nordisk keen on diabetes R&D in India |
| BS Reporter / New Delhi February 6, 2008 |
| Novo Nordisk, the $18.5 billion global leader in diabetes care, is planning to expand its drug discovery and manufacturing presence in India. The company, which employs over 600 persons in India currently, is to triple its staff strength in four years. It is also firming up long term partnerships with Indian firms in key areas of drug discovery, financial management and sales, Melvin Oscar D |
